Surprisingly, both the highest prevalence of quantifiable plasma CCL20 (Figure 1C) and plasma CCL20 levels (Figure 1D) were found in patients with early DKD (better preserved eGFR) and were significantly lower in individuals with more advanced CKD than with early CKD. Here, CCL20 is linked to chronic kidney disease.